Annotation Detail for CUBN
Basic Information
Top
Pathway ID | Pathway Name |
---|
| Hormone biosynthesis |
| Metabolism of vitamins and cofactors |
| Metabolism of lipids and lipoproteins |
Pathway ID | Pathway Name |
---|
500600 | Vitamin D (calciferol) metabolism |
500797 | HDL-mediated lipid transport |
Desease Name |
---|
quantitative traits |
METABOLIC |
folate pathway vitamin levels |
Desease Name |
---|
Folate pathway vitamin levels |
Quantitative traits |
Desease Name |
---|
Megaloblastic anemia-1, Finnish type |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CUBN mRNA | affects expression | 16483693
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CUBN mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CUBN mRNA | decreases expression | 17426115
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CUBN mRNA | increases expression | 16236135
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.64 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.22 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.98 | 15955085 |
MESH:D000749 |
Anemia, Megaloblastic |
marker/mechanism |
|
| |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.32 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.34 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.44 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.99 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.63 | 16206674 16197459 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.23 | 16443354 16166294 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.33 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
6.03 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.38 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.32 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.33 | 16129372 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.15 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
6.03 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.81 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.35 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 17551590 9224671 8800419 9125849 10589399 9211117 16925845 9142499 9664655 14991402 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.59 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.96 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.33 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.37 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.90 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.25 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.16 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.27 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.46 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
6.03 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.09 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.78 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.64 | 19772884 16221962 18467677 19176532 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.57 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.22 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.63 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.90 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.42 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.39 | 17551590 15992940 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.95 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.18 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.13 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.42 | 19035177 17506722 19642359 15748426 16140955 16331271 16891316 17301526 17107899 16766008 17712046 19029980 17339181 19225113 17649720 17368321 9834237 12679006 17217047 16935935 16823087 16788101 17294898 19075265 17361223 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.62 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.44 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.44 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.94 | 15890375 16377806 20007298 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.92 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.99 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
5.08 | 16940565 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.16 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.30 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.29 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.29 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.53 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.53 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.36 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.32 | 9142499 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.89 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.45 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.28 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.58 | 15976015 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.13 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.54 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.56 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.63 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.78 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.36 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.24 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.47 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.12 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.48 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.64 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.39 | 16287080 |
PharmGKB Accession:PA27044
Releated disease ID |
Related disease Name |
PA443560 | Breast Neoplasms |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00115 |
- |
Liver-Stomach Concentrate with Intrinsic Factor |
Antianemic Agents;Essential Vitamin;Vitamins (Vitamin B Complex) |
DB00200 |
other |
Vege 1 Daily Caplet |
Nutritional Supplement;Anti-anemic Agents;Vitamin B Complex;Hematinics |